A Comparison of Seroquel vs. Risperidone in Schizophrenia

• Status: Completed
• Trial end date: 2002-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to show equal efficacy of both quetiapine and risperidone in subjects treated with study medication for up to 8 weeks.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Quetiapine Fumarate; Risperidone

Criteria

Inclusion Criteria

• Male / Female, 18-65 years old

• Schizophrenia (as per DSM IV)

Exclusion Criteria

• Concurrent use of psychotropic medication

• Does not fulfill moderately ill on CGI